Sankala Group’s Astera Labs ALAB Stock Holding History

Sankala Group’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.4K	Hold	30	–	–	﹤0.01%	460
2025 Q4	$3.56K	Buy	+30	New	+$5.02K	﹤0.01%	471

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Sankala Group's ALAB Position: Q1 2026 in Review

Sankala Group held its Astera Labs (ALAB) position steady in Q1 2026 at 30 shares worth $3.4K. The position accounts for ﹤0.01% of the portfolio, ranked #460.

Sankala Group first reported a position in ALAB in Q4 2025 and has held it in 2 quarters since. The position peaked at $3.56K in Q4 2025. 706 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

Sankala Group held 30 shares of Astera Labs worth $3.4K as of Q1 2026.
Sankala Group left its Astera Labs share count unchanged in Q1 2026.
Astera Labs made up ﹤0.01% of Sankala Group's portfolio in Q1 2026, its #460 holding.
Sankala Group first reported a position in Astera Labs in Q4 2025 and has held it in 2 quarters since.
Sankala Group's Astera Labs position peaked at $3.56K in Q4 2025.
706 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Sankala Group's 13F filing for Q1 2026, filed 31 Mar 2026.